trending Market Intelligence /marketintelligence/en/news-insights/trending/ynnlooejhkr-5ab9pn1qzw2 content esgSubNav
In This List

Valens GroWorks makes changes to board


Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection


Japan M&A By the Numbers: Q4 2023


Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Valens GroWorks makes changes to board

Canadian cannabis company Valens Groworks Corp. announced a change in its board.

Chris Irwin, Nitin Kaushal, Ashley McGrath and Chris Buysen joined the company as directors, while John Cullen and Robert O'Brien stepped down from the board.

O'Brien also resigned as the company's chief science officer.

Cullen had been a board member since February, and O'Brien became a director in April 2017.

Irwin is a partner in the Toronto law firm of Irwin Lowy LLP, focused on securities and corporate/commercial law. He advises a number of public companies on matters including continuous disclosure and regulatory matters, reverse takeover transactions, initial public offerings, and takeover bids.

Kaushal is managing director of corporate finance at PwC Canada. He has more than 30 years of finance and investment expertise, including senior roles with Canadian investment banks and various roles within the private equity/venture capital industry.

McGrath has been involved in real estate development for 14 years. He oversees the management of a large rental portfolio of residential and commercial real estate and is a shareholder in an agribusiness operating more than 400,000 square feet of indoor livestock production as well as a 23,000-acre grain farm.

Tyler Robson, the company's CEO, said strengthening the board was a top priority as Valens Groworks seeks to expand both domestically and internationally.